Dr William Withroe Young, MD in Hanover, NH - Obstetrics & Gynecology

Dr William Withroe Young, MD is a Obstetrics & Gynecology - Gynecology physician based in Hanover, New Hampshire. Dr William Withroe Young is licensed to practice in New Hampshire (license number 5534) and his current practice location is 22 Rope Ferry Rd, Hanover, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 643-2224.

NPI number for Dr William Withroe Young is 1851721567 and his current mailing address is 22 Rope Ferry Rd, Hanover, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1851721567.

Contact Information

	Dr William Withroe Young, MD
	22 Rope Ferry Rd, Hanover, NH 03755-1405
	(603) 643-2224
	Not Available

Physician's Profile

Full Name	Dr William Withroe Young
Gender	Male
Speciality	Obstetrics & Gynecology - Gynecology
Location	22 Rope Ferry Rd, Hanover, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1851721567
Provider Enumeration Date: 11/15/2013
Last Update Date: 11/15/2013

Medical Identifiers

Medical identifiers for Dr William Withroe Young such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1851721567	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207VG0400X	Obstetrics & Gynecology - Gynecology	5534 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William Withroe Young is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William Withroe Young, MD 22 Rope Ferry Rd, Hanover, NH 03755-1405 Ph: (603) 643-2224	Dr William Withroe Young, MD 22 Rope Ferry Rd, Hanover, NH 03755-1405 Ph: (603) 643-2224

News Archive

Study: Somatostatin treatment in cerebral cortex may improve visual processing, cognitive behaviors

Researchers have confirmed that neuropeptide somatostatin can improve cognitive function in the brain. A research group of Professor Seung-Hee Lee from the Department of Biological Sciences at KAIST found that the application of neuropeptide somatostatin improves visual processing and cognitive behaviors by reducing excitatory inputs to parvalbumin-positive interneurons in the cortex.

Over 700 Chinese patients with acute myeloid leukemia undergo Microtransplantation treatment

According to Dr. Huisheng Ai's team, founder of Microtransplantation regimen mainly for Acute Myeloid Leukemia, over 700 patients have undergone this therapy since its emergence in 2002. Based at MST International Clinic for Leukemia in the 307th Hospital of Chinese People's Liberation Army in Beijing, about 40 hematology centers covering all main hospitals in 32 provinces of mainland China have adopted Microtransplantation regimen.

Escherichia coli cases drop in 2009

As per a report from the Centers for Disease Control and Prevention (CDC) a 12 % drop in rates of Escherichia coli (E.coli) infection has been noted in 2009 as compared to statistics for 2008. This is being seen by federal health officials as a sign that the new food safety measures are effective. Most of the pathogens under study are from the bacteria family like E.coli 0157, salmonella, campylobacter, listeria and vibrio. It was found that food poisoning rates for the most common pathogens have changed little from statistics collected in 2004.

Researchers receive $2.66 million NIH grant to improve asthma management in minority emerging adults

Older adolescents and young adults are at the highest risk for poor asthma management and health outcomes, but few studies have been published on this issue.

Radical prostatectomy may be a safe option for the treatment of prostate cancer

Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.

Dr William Withroe Young, MD - Obstetrics & Gynecology in Hanover, NH